Cefazolin Alone Versus Cefazolin With Tobramycin or Gentamicin As Intraoperative Antibiotic Prophylaxis for Total Joint Arthroplasty

Overview

Journal Arthroplast Today

Publisher Elsevier

Date 2025 Feb 6

PMID 39911247

Authors

Meera M Dhodapkar

Scott J Halperin

Zachary Radford

Lee E Rubin

Jonathan N Grauer

Mengnai Li

Affiliations

Soon will be listed here.

Abstract

Background: Prosthetic joint infection is a serious complication of total knee arthroplasty (TKA) and total hip arthroplasty (THA). While cefazolin is the standard prophylactic antibiotic, some groups have considered adding aminoglycosides (gentamycin or tobramycin) to this regimen.

Methods: Adult primary THA and TKA patients were identified from 2010-2021 Q1 PearlDiver M151 database. Inclusion criteria were activity in the database ≥ 90 days postoperative and no infectious, neoplastic, or traumatic diagnoses within 90 days preoperative. Intraoperative antibiotic prophylaxis regimens were determined using Current Procedural Terminology J codes. For both THA and TKA, 2 subcohorts were created: (1) Patients who received cefazolin alone and (2) cefazolin and tobramycin or gentamicin. Differences in 90-day postoperative adverse outcomes were assessed with multivariable logistic regression controlling for age, sex, and Elixhauser Comorbidity Index. Five-year implant survival was assessed using Kaplan-Meier analysis and log-rank tests.

Results: For THA, 32,882 patients were identified, prophylactic cefazolin alone was given to 30,527 (92.8%), and cefazolin + gentamicin/tobramycin was given to 2355 (7.2%). For TKA, 119,611 patients were identified, prophylactic cefazolin alone was given to 110,469 (92.4%), and cefazolin + gentamicin/tobramycin was given to 9142 (7.6%). Overall SSI rate for THA was 1.1% and for TKA 0.8%. For both THA and TKA, antibiotic subgroups were clinically similar with regard to age, sex, and Elixhauser Comorbidity Index. On univariable and multivariable analysis, no 90-day outcomes varied significantly. Five-year implant survivals were not significantly different.

Conclusions: For THA and TKA, cefazolin alone vs cefazolin + gentamicin/tobramycin were not found to have differences in rates of perioperative adverse outcomes (including SSI/prosthetic joint infection) or 5-year revision rates.

References

Berbari E, Hanssen A, Duffy M, Steckelberg J, Ilstrup D, Harmsen W . Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis. 1998; 27(5):1247-54. DOI: 10.1086/514991. View

Iorio R, Williams K, Marcantonio A, Specht L, Tilzey J, Healy W . Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection. J Arthroplasty. 2011; 27(5):726-9.e1. DOI: 10.1016/j.arth.2011.09.013. View

Gouzoulis M, Kammien A, Caruana D, Wiznia D, Grauer J . Hidradenitis Suppurativa Leads to Increased Risk of Wound-Related Complications following Total Joint Arthroplasty. Arthroplast Today. 2022; 16:169-174. PMC: 9249970. DOI: 10.1016/j.artd.2022.05.013. View

Halperin S, Dhodapkar M, Radford Z, Frumberg D, Rubin L, Grauer J . Patients With Down Syndrome and Total Hip and Total Knee Arthroplasty: Outcome Measures Show Increased Risk of Perioperative Complications. J Am Acad Orthop Surg Glob Res Rev. 2023; 7(12). PMC: 10697628. DOI: 10.5435/JAAOSGlobal-D-23-00108. View

Kammien A, Galivanche A, Gouzoulis M, Moore H, Mercier M, Grauer J . Emergency department visits within 90 days of single-level anterior cervical discectomy and fusion. N Am Spine Soc J. 2022; 10:100122. PMC: 9144013. DOI: 10.1016/j.xnsj.2022.100122. View

Ratnasamy P, Rudisill K, Caruana D, Kammien A, Grauer J . Emergency department visits within 90 days of lumbar discectomy. Spine J. 2023; 23(10):1522-1530. DOI: 10.1016/j.spinee.2023.06.384. View

Bratzler D, Dellinger E, Olsen K, Perl T, Auwaerter P, Bolon M . Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt). 2013; 14(1):73-156. DOI: 10.1089/sur.2013.9999. View

Ahmed S, Begum F, Kayani B, Haddad F . Risk factors, diagnosis and management of prosthetic joint infection after total hip arthroplasty. Expert Rev Med Devices. 2019; 16(12):1063-1070. DOI: 10.1080/17434440.2019.1696673. View

Halperin S, Dhodapkar M, Radford Z, Li M, Rubin L, Grauer J . Total Knee Arthroplasty: Variables Affecting 90-day Overall Reimbursement. J Arthroplasty. 2023; 38(11):2259-2263. DOI: 10.1016/j.arth.2023.05.072. View

10.

Bosco J, Prince Rainier R Tejada , Catanzano A, Stachel A, Phillips M . Expanded Gram-Negative Antimicrobial Prophylaxis Reduces Surgical Site Infections in Hip Arthroplasty. J Arthroplasty. 2015; 31(3):616-21. DOI: 10.1016/j.arth.2015.09.051. View

11.

Elixhauser A, Steiner C, Harris D, Coffey R . Comorbidity measures for use with administrative data. Med Care. 1998; 36(1):8-27. DOI: 10.1097/00005650-199801000-00004. View

12.

Kammien A, Ratnasamy P, Joo P, Grauer J . Ninety-Day Emergency Department Visits After Ankle Fracture Surgery. J Am Acad Orthop Surg. 2022; 31(1):e51-e57. DOI: 10.5435/JAAOS-D-22-00484. View

13.

Bojan B, Perni S, Prokopovich P . Systematic Review and Meta-Analysis of Tobacco Use as a Risk Factor for Prosthetic Joint Infection After Total Hip Replacement. Arthroplast Today. 2021; 6(4):959-971. PMC: 7772455. DOI: 10.1016/j.artd.2020.07.011. View

14.

Benito N, Franco M, Ribera A, Soriano A, Rodriguez-Pardo D, Sorli L . Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study. Clin Microbiol Infect. 2016; 22(8):732.e1-8. DOI: 10.1016/j.cmi.2016.05.004. View

15.

Luo S, Lai Y, Liu C, Chen Y, Qiao X . Prophylactic use of gentamicin/flucloxacillin versus cefuroxime in surgery: a meta analysis of clinical studies. Int J Clin Exp Med. 2016; 8(10):17856-67. PMC: 4694280. View

16.

Delanois R, Mistry J, Gwam C, Mohamed N, Choksi U, Mont M . Current Epidemiology of Revision Total Knee Arthroplasty in the United States. J Arthroplasty. 2017; 32(9):2663-2668. DOI: 10.1016/j.arth.2017.03.066. View

17.

Ratnasamy P, Rudisill K, Gouzoulis M, Kammien A, Grauer J . Rheumatoid arthritis patients are at increased risk for adverse events following lumbar discectomy. Spine J. 2023; 23(7):990-996. DOI: 10.1016/j.spinee.2023.03.012. View

18.

AlBuhairan B, Hind D, Hutchinson A . Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. J Bone Joint Surg Br. 2008; 90(7):915-9. DOI: 10.1302/0301-620X.90B7.20498. View

19.

Phillips J, Crane T, Noy M, Elliott T, Grimer R . The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br. 2006; 88(7):943-8. DOI: 10.1302/0301-620X.88B7.17150. View

20.

Halperin S, Dhodapkar M, Radford Z, Kaszuba S, Rubin L, Grauer J . Patients With Cystic Fibrosis Undergoing Total Hip and Total Knee Arthroplasty Are at Increased Risk for Perioperative Complications. J Am Acad Orthop Surg. 2024; 32(7):309-315. DOI: 10.5435/JAAOS-D-23-00783. View